Lynch Regenerative Medicine Hires Hee as Chief Scientific Officer
FRANKLIN, Tenn.--(BUSINESS WIRE)--Lynch Regenerative Medicine, LLC., (LRM) and its wholly owned subsidiaries LRM Aesthetics, Inc. (LRMA), and LRM WoundCare, Inc. (LRMW), announced today that Charlie Hee, Ph.D., will join its team as Chief Scientific Officer (CSO) across all companies, effective immediately.
Dr. Hee is an experienced translational scientist and strategic leader, with more than 20 years of industry and research experience. Trained in tissue engineering, with a doctorate from the University of Pennsylvania, Dr. Hee has a keen interest in novel product applications incorporating growth factors, stem cells and biologic scaffolds to drive regenerative healing. With experience in developing products for use in aesthetic medicine and reconstructive surgery, Dr. Hee was identified as an ideal fit for LRM's focus areas in aesthetics and wound care.
'As CSO, Dr. Hee will have responsibility for leading all our teams in Phase I through IV clinical trials, non-clinical research, new product development, quality control, and manufacturing for LRM, LRMA and LRMW. His previous experience with recombinant pure PDGF, and the aesthetic and regenerative medicine fields, make him ideal to work with our current team members to drive further success in these areas,' stated Dr. Samuel Lynch, founder and CEO of LRM.
Most recently, Dr. Hee served as vice president of Device R&D at Allergan Aesthetics, an Abbvie company, with responsibility for device product development, biological research, and biomaterials and drug delivery in support of Allergan Aesthetic's Fillers, Plastic and Regenerative Medicine, and Body Contouring franchises. Prior to that, Dr. Hee served as an associate director of research at BioMimetic Therapeutics, leading the scientific research evaluating recombinant pure platelet-derived growth factor-BB (PDGF-BB) for sports medicine and orthopedic applications.
About Lynch Regenerative Medicine, LLC
Lynch Regenerative Medicine, LLC., is pioneering innovative treatments that aim to revolutionize the $100 billion aesthetics and wound-care markets. Our mission is to leverage our regenerative medicine heritage, and our decades-long commitment to safe and effective regenerative products of the highest quality, to deliver exceptional results for our customers and their patients and thereby redefine the future of aesthetic regenerative medicine. The company was founded in 2023 by Dr. Lynch and is based in Franklin, Tennessee.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
WIRED
3 days ago
- WIRED
What Are Exosomes, and Why Are They in Your Skincare?
By now, you've probably seen 'exosomes' wafting across your For You Page, maybe sandwiched between a promo code for snail mucin and someone rendering beef tallow. Scroll through SkinTok long enough, and you'll hit a flood of videos hyping exosome therapy, exosome serums, and exosome treatments promising the skin health of a cherub. Skincare companies have seized the term. Marketed as miraculous regenerative agents, you'll find them on $300 facial menus, in post-micro-needling procedures, and across influencers' skincare routines. TikTok content This content can also be viewed on the site it originates from. What Are Exosomes? An exosome is a teeny sac inside a cell, or what a scientist might call an extracellular vesicle. They act as tiny mailbags, shuttling mRNAs, lipids, and other genetic material through the cell membranes from one cell to another. Exosomes are a part of the body's internal messaging system, regulating everything from cell growth to hormone production and gene expression. They're microscopic, measuring about 40 to 100 nanometers across, so small they make a red blood cell look massive in comparison. Scientists first discovered them under a microscope back in the 1960s, but they didn't gain significant attention until the early 2000s. Why Are Exosomes Controversial? In medicine, exosomes are being studied for cancer therapies, neurodegenerative diseases, and drug delivery systems. Because they reflect the state of the cells from which they originate, cancer cells often release exosomes that contain unique molecular fingerprints. Scientists are already using these biomarkers to assist in the early diagnosis of conditions like prostate cancer. The potential for early, non-invasive detection across a range of diseases is substantial. Because exosomes can cross biological barriers and deliver cargo, researchers are also exploring them as vehicles for targeted drugs. Additionally, they hold potential for wound healing, inflammation reduction, and tissue regeneration. Naturally, the beauty industry caught wind. Now, exosomes are in moisturizers, serums, and hair injectables, promising to repair your skin barrier, boost collagen production, and reverse aging.
Yahoo
3 days ago
- Yahoo
Energy Storage MoU Signed Between REPT BATTRO and Hyosung Heavy Industries
SHANGHAI, May 30, 2025 /PRNewswire/ -- On May 27, 2025, REPT BATTERO and Hyosung Heavy Industries formally signed a Memorandum of Understanding (MoU) in Seoul, South Korea, focusing on battery energy storage systems. REPT BATTERO will supply 2.5GWh of energy storage products, jointly promoting the application and popularization of energy storage technology in the global market. Centered on establishing a global strategic framework for energy storage, REPT BATTERO will deliver energy storage cells, modules, and DC containers to Hyosung Heavy Industries, while providing technical support for system design integration and quality control. Hyosung Heavy Industries will assume responsibilities for global marketing, regional localization, and regulatory certification. Through the 2.5GWh supply partnership, both entities seek to progressively establish a dominant position in the global energy storage market, underpinning their commitment to advancing scalable and sustainable energy solutions worldwide. Woo Tae-hee, the CEO & President of Hyosung Heavy Industries stated, "Hyosung Heavy Industries is dedicated to becoming a global leader in energy solutions, and this collaboration will further solidify our market positions in the energy storage sector. We will closely collaborate with REPT BATTERO to deliver innovative products and services to global customers." Feng Ting, the CEO & President of REPT BATTERO remarked, "This signing marks a significant breakthrough in market synergy between Chinese and South Korean energy storage enterprises. As a global leading battery technology supplier, REPT BATTERO's high-efficiency energy storage batteries complement Hyosung Heavy Industries' deep expertise in the global power industry. Through deep cooperation, the two sides will provide professional products and services to more overseas customers." REPT BATTRO and Hyosung Heavy Industries affirmed their commitment to building upon this strategic partnership to strengthen collaboration in international markets, collectively tackle climate change challenges, and contribute Chinese and Korean insights and solutions to the global energy transition. About Hyosung Heavy Industries Hyosung Heavy Industries, founded in 1977, is a leading Korean company recognized for its global competitiveness in high- and ultra-high-voltage power equipment and energy infrastructure. Hyosung commands the No.1 market share for power transformers in Korea, holds approximately 40% share in the domestic low-voltage motor market, and has accumulated more than KRW 10 trillion in circuit breaker salesboth locally and globally. In Europe, Hyosung leads the 400kV transformer market, especially in Norway with over 80% market share. With decades of EPC experience and strong system engineering capabilities, Hyosung Heavy Industries supplies high-reliability power systems to the Middle East, Southeast Asia, the Americas, and Europe. By addressing global trends toward decarbonization, decentralization, and digitalization in the energy sector, the company is positioning itself as a key enabler of sustainable, global energy transformation. View original content to download multimedia: SOURCE REPT BATTERO Energy Co., Ltd. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 days ago
- Yahoo
GM, LG Energy target commercializing manganese-rich batteries for EVs
This story was originally published on Automotive Dive. To receive daily news and insights, subscribe to our free daily Automotive Dive newsletter. Battery engineers at General Motors and its joint venture partner LG Energy Solution have developed an improved lithium manganese-rich (LMR) prismatic battery cell design for the company's future electric vehicles, the automaker announced in a May 13 press release. The LRM battery chemistry uses a higher percentage of lower-cost manganese to replace Cobalt, a critical raw material for EV batteries, making them less costly to produce while still delivering high energy density. GM aims to be the first major automaker to deploy LMR batteries in EVs. Its Ultium Cells joint venture with LG Energy plans to start commercial production of the battery cells in the U.S. by 2028 for full-size electric trucks and SUVs. GM's current EV models use nickel manganese cobalt aluminum oxide (NMCA) batteries, which contributes to improving driving range, but are costlier manufacture. LRM battery chemistry, on the other hand, can help GM make its future EVs more affordable. A high nickel battery cell typically consists of roughly 85% nickel, 10% manganese and 5% cobalt, according to GM. But LMR cells contain around 35% nickel, 65% manganese, and 'virtually no cobalt,' which can significantly reduce costs. In addition, GM says its LMR prismatic battery cell design has 33% higher energy density compared to the best-performing lithium iron phosphate (LFP) or manganese cobalt aluminum oxide (NMCA) cells used in many EVs on the road today, and at a comparable cost. The new LRM battery cells are not intended to replace GM's current batteries. Rather they will be used for some electric models along with high-nickel and iron-phosphate cells for others. According to GM, the lower cost LRM prismatic cell batteries will primarily be used to expand customer choice in the electric truck and full-size SUV markets. 'We're pioneering manganese-rich battery technology to unlock premium range and performance at an affordable cost, especially in electric trucks,' said Kurt Kelty, VP of battery, propulsion, and sustainability at GM, in the release. 'As we look to engineer the ideal battery for each vehicle in our diverse EV portfolio, LMR will complement our high-nickel and iron-phosphate solutions.' GM is targeting driving ranges of over 400 miles for its full-size electric trucks and SUVs equipped with LRM batteries, while achieving significant cost savings compared to today's high-nickel battery cells the automaker is currently using. The automaker said it began researching LRM battery cells a decade ago, which included prototyping cells at its Wallace Battery Cell Innovation Center in Warren, Michigan. The automaker accelerated its research in 2020 as its engineers collaborated with partners including LG Energy to achieve advancements in battery cathode materials, electrolytes, additives, form factors and assembly processes. GM said researchers overcame LMR's limitations in performance and durability that made them impractical for commercial use, according to the company. 'We've worked with our suppliers to optimize the materials in our LMR cells, adding proprietary dopants and coatings, along with particle engineering, process innovations, to achieve the right energy density and arrangement of battery materials inside the cell to keep them stable,' said Kushal Narayanaswamy, director of advanced battery cell engineering at GM, in a May 13 blog post. By the end of 2024, GM said its researchers coated roughly one metric ton of LMR cathode material at the company's Wallace Battery Cell Innovation Center, which included testing hundreds of large format prismatic cells in 18 different prototypes and three cell dimensions. In total, the tests were equivalent to 1.4 million miles of EV driving, according to GM. Unlike the 4680 cylindrical cell format used by Tesla for the Model Y, prismatic cells can be stacked closer together inside an EV's battery pack. Their flat design uses less space compared to cylindrical cell batteries, leading to higher energy density, as more cells can fit into each EV battery pack. The cells can also better dissipate heat for improved cooling performance with an outer case typically made of aluminum. 'That makes them substantially more efficient to package in full-scale trucks and SUVs,' Narayanaswamy said. Prismatic cells also require fewer components to assemble battery packs, which contributes to lower costs. The design can reduce battery module components by 75% and total pack components by 50%, according to GM. Pre-production of LRM battery cells is expected to begin at an LG Energy Solution facility by late 2027. The final cell design will be validated at GM's new Battery Cell Development Center in Warren, Michigan, that's expected to be operational by 2027. The batteries will also be validated at an unnamed LG Energy Solution facility before series production begins. 'We're excited to introduce the first-ever LMR prismatic cells for EVs, the culmination of our decades-long research and investment in the technology,' said Wonjoon Suh, executive VP and head of the Advanced Automotive Battery division at LG Energy Solution, in the release. 'GM's future trucks powered by this new chemistry are a strong example of our shared commitment to offering diverse EV options to consumers.' Recommended Reading LG Energy Solution picks up Michigan's subsidies for Ultium plant Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
